Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial

Chen, YD; Yuan, ZY; Lu, JM; Eliaschewitz, FG; Lorenzatti, AJ; Monsalvo, ML; Wang, N; Hamer, AW; Ge, JB

Chen, YD (reprint author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, 28 Fuxing Rd, Beijing, Peoples R China.

DIABETES OBESITY & METABOLISM, 2019; 21 (6): 1464

Abstract

Aim The aim of this study was to evaluate the efficacy and safety of evolocumab with background atorvastatin in Chinese patients with type 2 diabetes ......

Full Text Link